ALKERMES | ALKS - Capital Social e Reservas

Preço das Ações
33.59
Mudança Diária
-0.13 -0.37%
Mensal
-3.60%
Anual
5.68%
Q2 Previsão
32.32




Capital Social e Reservas Alterar Data
AbbVie USD -3.27B 628M 2025-12
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
ALKERMES USD 1.82B 85.86M 2025-12
Amgen USD 9.19B 532M 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 22.62B 1.16B 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
J&J USD 81.19B 358M 2026-03
Malin Corporation EUR 193.2M 75M 2024-12
Merck USD 52.61B 756M 2025-12
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Otsuka Holdings JPY 3.11T 74.63B 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12